Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Prior radioprotection via EGLN inhibitor improves survival in mouse model of pancreatic cancer

Administration of the EGLN inhibitor FG-4592 prior to ablative radiotherapy provided protection against fatal gastrointestinal bleeding and improved survival in a mouse model of unresectable pancreatic cancer.

30 Apr 2019

Combination of biological markers and genetic changes can predict radiation sensitivity

Latest results from a project to discover what makes a cancer patient more likely to suffer adverse side-effects after radiotherapy have shown that a combination of biological markers and certain genetic changes can predict radiation sensitivity.

30 Apr 2019

Pencil beam scanning proved best for preserving cognitive functions in children with brain tumor

A comparison of three types of radiotherapy for children's brain tumors suggests that a type of proton therapy called pencil beam scanning offers the best hope of preserving cognitive functions.

30 Apr 2019

Single high dose of radiation targeted directly to tumor is safe and effective for prostate cancer

A single high dose of radiation that can be delivered directly to the tumor within a few minutes is a safe and effective technique for treating men with low risk prostate cancer, according to a study presented at the ESTRO 38 conference.

29 Apr 2019

Mesothelioma patients twice as likely to survive when treated with high dose of radiation

Mesothelioma patients are twice as likely to survive for two years or longer, if they are treated with a high dose of radiation to the affected side of the trunk, according to research presented at the ESTRO 38 conference.

29 Apr 2019

Patients with advanced Hodgkin's lymphoma may benefit from radiotherapy after chemotherapy

Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy after chemotherapy even when all traces of the cancer appear to have gone, according to late breaking results presented at the ESTRO 38 conference today.

29 Apr 2019

Combination of radiotherapy and anti-hormone treatment can prevent recurrence of hormone-driven breast cancer

Women with early, low risk, hormone-driven breast cancer are less likely to have a recurrence of their disease if they have radiotherapy after surgery, as well as anti-hormone treatment, according to results from a trial that has followed 869 women for ten years.

26 Apr 2019

Six factors associated with invasive breast cancer recurrence after DCIS diagnosis

Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to data from a meta-analysis.

25 Apr 2019

New range prediction approach increases accuracy, safety and tolerability of proton therapy

Today (Tuesday, 23 April) marks the beginning of a new era in treatment planning at the University Proton Therapy Dresden of the University Hospital in Dresden (Germany): For the worldwide first time, a new approach increases the accuracy, safety and probably also the tolerability of proton therapy.

24 Apr 2019

NUS scientists uncover novel biomarkers linked with ‘chemobrain’

Cognitive impairment associated with cancer, also known as "chemobrain", has gained recognition as a complication of the disease and its treatment, as it can negatively affect the daily lives of cancer patients and survivors.

23 Apr 2019

Three studies show how tumors hijack the immune system to develop radiotherapy resistance

More than a decade ago, radiation oncologists noticed a nifty phenomenon: Sometimes radiation used locally against a tumor could excite the immune system to attack cancer systemically throughout the body.

17 Apr 2019

UCD based healthcare start-up receives funding and plans expansion into US market

A University College Dublin based start-up, THEYA Healthcare (www.theyahealthcare.com), which designs and manufactures healthcare garments, has secured an investment of €665,000.

10 Apr 2019

Biologists analyze available methods of targeted drug delivery to malignant tumors

A team of biologists from Sechenov First Moscow State Medical University and Lobachevsky University analyzed available methods of targeted drug delivery to malignant tumors.

9 Apr 2019

Varian presents first preclinical results of breakthrough cancer therapy research

At the American Association for Cancer Research Annual Meeting in Atlanta, GA, Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the Maryland Proton Treatment Center, presented publicly the first pre-clinical results of its research on ultra-high dose rate cancer treatments with protons.

From American Association for Cancer Research-AACR Annual Meeting 2019 8 Apr 2019

Radiotherapy News and Research

Further Reading

Prior radioprotection via EGLN inhibitor improves survival in mouse model of pancreatic cancer

Combination of biological markers and genetic changes can predict radiation sensitivity

Pencil beam scanning proved best for preserving cognitive functions in children with brain tumor

Single high dose of radiation targeted directly to tumor is safe and effective for prostate cancer

Mesothelioma patients twice as likely to survive when treated with high dose of radiation

Patients with advanced Hodgkin's lymphoma may benefit from radiotherapy after chemotherapy

Combination of radiotherapy and anti-hormone treatment can prevent recurrence of hormone-driven breast cancer

Six factors associated with invasive breast cancer recurrence after DCIS diagnosis

New range prediction approach increases accuracy, safety and tolerability of proton therapy

NUS scientists uncover novel biomarkers linked with ‘chemobrain’

Three studies show how tumors hijack the immune system to develop radiotherapy resistance

UCD based healthcare start-up receives funding and plans expansion into US market

Biologists analyze available methods of targeted drug delivery to malignant tumors

Varian presents first preclinical results of breakthrough cancer therapy research

High-dose standard radiation treatment well-tolerated by patients with centrally located NSCLC

Cervical cancer mortality rate found to be higher among older women

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

UC San Diego Health treats first cancer patient with iPSC-derived cell therapy

Queen’s University Belfast and Domainex identify novel first-in-class FLIP inhibitors

Prostate cancer cells 'spit out' a protein that promotes tumor growth

Cancer Research - Second Edition eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News